Skip to main content
. 2016 Jul 14;11(7):e0159138. doi: 10.1371/journal.pone.0159138

Table 5. Evaluation of four feature selection methods for defining a condensed biomarker signature for classification of two groups, using a 3-fold cross validation scheme repeated twice.

The length of the biomarker signature was set to 25. A linear SVM classifier was used to assess the performance in all cases, except for RF (RF), where random forest was used both for the ranking and the final AUC calculation. AUC values are given together with standard deviations. The biomarker overlap was defined as the number of common biomarkers between two signatures.

Method Sample cohort 2 Sample cohort 3
Biomarker overlap Biomarker overlap
BE-SVM SVMc RF BE-SVM SVMc RF
ROC AUC ROC AUC
p-value 90.1 (2.3) 3 4 15 90.6 (1.3) 8 7 20
BE-SVM 95.9 (3.2) 17 6 93.5 (1.1) 15 9
SVMc 96.7 (2.1) 7 92.1 (0.5) 9
RF (SVM) 94.5 (1.3) 91.7 (0.8)
RF (RF) 95.1 (2.1) 90.9 (0.8)